Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study. Issue 5 (22nd March 2022)

Record Type:
Journal Article
Title:
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study. Issue 5 (22nd March 2022)
Main Title:
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study
Authors:
Ghazanfar, Misbah Noshela
Bartko, Ewa Anna
Arildsen, Nicolai Skovbjerg
Poulsen, Lars K.
Jensen, Bettina Margrethe
Enevold, Christian
Holm, Jesper Grønlund
Woetmann, Anders
Ødum, Niels
Thomsen, Simon Francis
Abstract:
Is Part Of:
Clinical & experimental allergy. Volume 52:Issue 5(2022)
Journal:
Clinical & experimental allergy
Issue:
Volume 52:Issue 5(2022)
Issue Display:
Volume 52, Issue 5 (2022)
Year:
2022
Volume:
52
Issue:
5
Issue Sort Value:
2022-0052-0005-0000
Page Start:
715
Page End:
718
Publication Date:
2022-03-22
Subjects:
body mass index -- chronic urticaria -- IgE -- omalizumab -- pharmacokinetics
Allergy -- Periodicals
Immunology -- Periodicals
616.97
Journal URLs:
http://www.blackwellpublishing.com/journal.asp?ref=0954-7894&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2222 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1111/cea.14121 ↗
Languages:
English
ISSNs:
0954-7894
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3286.249700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
27147.xml